EUCTR2010-023669-23-SK进行中（未招募）1 期
Multicenter, Open-Label, Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Genotype 1 Chronic Hepatitis C Subjects With Severe Fibrosis and Compensated Cirrhosis
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,772
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patient must have evidence of chronic Hepatitis C (genotype 1) infection.
- •2. Patient must have documentation of liver fibrosis assessed by liver biopsy or noninvasive test showing severe fibrosis or cirrhosis
- •3. Evidence of compensated liver disease
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 48
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
排除标准
- •1. Patient is infected or co-infected with HCV of another genotype than genotype 1
- •2. Patient has signs or symptoms of HCC
- •3. Patient has a history of decompensated liver disease
- •4. Patient has a co-infection with active hepatitis B or HIV
研究者
相似试验
进行中（未招募）
不适用
Multicenter, Open-Label, Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Genotype 1 Chronic Hepatitis C Subjects With Severe Fibrosis and Compensated Cirrhosis -EUCTR2010-023669-23-DEJanssen Medical Affairs EMEA3,000
进行中（未招募）
不适用
Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Chronic Hepatitis C Genotype 1 Subjects With Severe fibrous tissue formation and liver damage.Chronic hepatitis C infectionMedDRA version: 15.1Level: LLTClassification code 10019752Term: Hepatitis C virus (HCV)System Organ Class: 100000004848EUCTR2010-023669-23-CZJanssen-Cilag International NV3,000
进行中（未招募）
不适用
Multicenter, Open-Label, Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Genotype 1 Chronic Hepatitis C Subjects With Severe Fibrosis and Compensated Cirrhosis - NDEUCTR2010-023669-23-ITJanssen-Cilag International N.V3,000
进行中（未招募）
不适用
Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Chronic Hepatitis C Genotype 1 Subjects With Severe fibrous tissue formation and liver damage.EUCTR2010-023669-23-HUJanssen-Cilag International NV3,216
进行中（未招募）
不适用
Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Chronic Hepatitis C Genotype 1 Subjects With Severe fibrous tissue formation and liver damage.Chronic hepatitis C infectionMedDRA version: 15.1Level: LLTClassification code 10019752Term: Hepatitis C virus (HCV)System Organ Class: 100000004848EUCTR2010-023669-23-ATJanssen-Cilag International NV3,000